- Corporate Officers - B
- Bogle Grant C.
Insider Trading History of Bogle Grant C.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bogle Grant C. since 2017.
This trader's CIK number is 1646675.
At the time of last reporting, Bogle Grant C. was the See Remarks of Epizyme, Inc.. (stock ticker symbol EPZM).
Also see all insider trading activities at Epizyme, Inc..
Note that in the past
Bogle Grant C. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Tesaro, Inc. (TSRO) by Bogle Grant C.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | TSRO | 0 | $0 | 1,809 | $99,223 | 5,858 | $0 |
| 2017 | TSRO | 0 | $0 | 15,614 | $2,169,546 | 15,625 | $579,937 |
Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Bogle Grant C.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | EPZM | 0 | $0 | 0 | $0 | 1,217,500 | $1,704,500 |
Insider trading activities at 2 companies by Bogle Grant C.:
1. Tesaro, Inc. (TSRO)
2. Epizyme, Inc. (EPZM)
Table 1. Insider trading of Tesaro, Inc. (TSRO) by Bogle Grant C.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-01 | TSRO | Sale | 1,809 | 54.85 | 99,223 |
| 2018-03-01 | TSRO | Option Ex | 5,858 | .00 | 0 |
| 2017-09-01 | TSRO | Sale | 14,167 | 135.00 | 1,912,545 |
| 2017-09-01 | TSRO | Option Ex | 11,250 | 51.55 | 579,937 |
| 2017-03-02 | TSRO | Sale | 1,447 | 177.61 | 257,001 |
| 2017-03-01 | TSRO | Option Ex | 4,375 | .00 | 0 |
Table 2. Insider trading of Epizyme, Inc. (EPZM) by Bogle Grant C.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-08-09 | EPZM | Option Ex | 1,217,500 | 1.40 | 1,704,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bogle Grant C.
(See Remarks of Epizyme, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.